Xencor to Present at Upcoming Investor Conferences
28 Février 2024 - 10:01PM
Business Wire
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical
company developing engineered antibodies for the treatment of
cancer and other serious diseases, today announced that company
management will participate at multiple upcoming investor
conferences:
- TD Cowen 44th Annual Health Care Conference Date:
Wednesday, March 6, 2024 Presentation Time: 12:50 p.m. ET / 9:50
a.m. PT Location: Boston
- Leerink Partners Global Biopharma Conference Date:
Tuesday, March 12, 2024 Presentation Date/Time: Wednesday, March
13, 2024, 9:20 a.m. ET / 6:20 a.m. PT Location: Miami
- Jefferies Biotech on the Bay Summit Date: Wednesday,
March 13, 2024 Location: Miami
- Barclays Global Healthcare Conference Date: Thursday,
March 14, 2024 Presentation Time: 11:15 a.m. ET / 8:15 a.m. PT
Location: Miami
Live webcasts of the Cowen, Leerink and Barclays presentations
will be available under “Events & Presentations” in the
Investors section of the Company’s website located at
www.xencor.com. Replays of the events will be available on the
Xencor website for at least 30 days following the
presentations.
About Xencor
Xencor is a clinical-stage biopharmaceutical company developing
engineered antibodies for the treatment of patients with cancer and
other serious diseases. More than 20 candidates engineered with
Xencor's XmAb® technology are in clinical development, and three
XmAb medicines are marketed by partners. Xencor's XmAb engineering
technology enables small changes to a protein's structure that
result in new mechanisms of therapeutic action. For more
information, please visit www.xencor.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240228121602/en/
Charles Liles cliles@xencor.com (626) 737-8118
Xencor (NASDAQ:XNCR)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Xencor (NASDAQ:XNCR)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024